Megan is a Biochemistry, Biophysics and Structural Biology PhD student in the Molecular Biology Institute at UCLA. Before coming to UCLA, she received her BS in Biochemistry from Northeastern University in 2020. Through undergraduate research inDr. Mary Jo Ondrechen’s lab, internships in both a startup pharmaceutical company and big pharma, and a two-year stint at the Center for the Development of Therapeutics at the Broad Institute, she has spent the beginning of her career investigating the underlying protein biochemistry of disease through the lense of drug discovery. At UCLA, she is interested in studying the molecular mechanisms of neurodegenerative disease to enhance the development of diagnostics and therapeutics through extracellular vesicle biology and modern mass spectrometry. She is co-mentored by Dr. Joseph Loo.

Headshot photo of Megan EM
Megan discovering the thrill of glow-discharging her negative-stain EM grids


B.S. - Northeastern University, Boston, MA, 2020.

  1. Hong M and Bitan G (2024) Recent advances and future therapy development for Alzheimer’s disease and related disorders. Neural Regener. Res., 19: 1877-1878.